Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
In this brief report, we share our observations on a splitted Dexamethasone implant (Ozurdex) which we discovered a week after the injection. It is likely that implant splitting neither changes the efficacy of the implant nor creates a mishap for the patient.
Saved in:
Main Authors: | Oya Donmez, Melih Parlak, Aylin Yaman, Ali Osman Saatci |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/247949 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
by: Erdem Eris, et al.
Published: (2017-01-01) -
Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography
by: Gabriela Assumpção Brito Pereira Pellegrini, et al.
Published: (2025-01-01) -
Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions
by: Muhammed Nurullah Bulut, et al.
Published: (2016-01-01) -
Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
by: Mohamed Loutfi, et al.
Published: (2014-01-01) -
Long-Term Follow-Up of the Postoperative Macular Fold following the Vitreoretinal Surgery with Air Tamponade
by: Ali Osman Saatci, et al.
Published: (2013-01-01)